Back to Search
Start Over
Do Gadolinium-Based Contrast Agents Affect 18 F-FDG PET/CT Uptake in the Dentate Nucleus and the Globus Pallidus? A Pilot Study.
- Source :
-
Journal of nuclear medicine technology [J Nucl Med Technol] 2017 Mar; Vol. 45 (1), pp. 30-33. Date of Electronic Publication: 2016 Nov 10. - Publication Year :
- 2017
-
Abstract
- Gadolinium is toxic and to avoid its deposition in tissues, it must be chemically bonded with nonmetal ions to facilitate its excretion by the kidneys. High signal intensity in the dentate nucleus (DN) and globus pallidus (GP) on unenhanced T1-weighted MR images has been both morphologically and pathologically linked to gadolinium-based contrast agent (GBCA) retention in the brain. The purpose of this study was to determine whether repeated administrations of GBCA would affect the uptake of <superscript>18</superscript> F-FDG in the DN and GP on PET/CT. Methods: Three hundred seventy-six patients who underwent both contrast-enhanced MR (CE MR) of the brain and PET/CT from January 2004 to October 2015 were identified. Patients with a history of brain irradiation or hepatic or renal disease were excluded. The SUV <subscript>max</subscript> was measured in the DN and GP on the PET/CT scan in patients who had 3-6 successive CE MR brain studies. The SUV <subscript>max</subscript> of the corresponding areas in the control group of patients who had not undergone previous CE MR and who had a normal, unenhanced MR finding of the brain was also measured. A Wilcoxon 2-sample test was used for statistical analysis. Results: Fifteen of 376 (4%) patients (mean age ± SD, 54 ± 18 y; 10 men and 5 women) were included in the subject group, and 15 patients (mean age ± SD, 36 ± 9 y; 11 men and 4 women) were included in the control group. The median DN SUV <subscript>max</subscript> was significantly lower in the subject group than in the control group (5.4 vs. 6.4, respectively; P = 0.021). Similarly, the median GP SUV <subscript>max</subscript> was significantly lower in the subject group than in the control group (8.8 vs. 12.1, respectively; P = 0.003). Conclusion: The median SUV <subscript>max</subscript> in the DN and GP was 16% and 27% lower, respectively, in patients who received GBCAs than in those who had not received GBCAs, possibly related to gadolinium deposition in these areas.<br /> (© 2017 by the Society of Nuclear Medicine and Molecular Imaging.)
- Subjects :
- Adult
Biological Transport drug effects
Cerebellar Nuclei diagnostic imaging
Contrast Media pharmacology
Female
Globus Pallidus diagnostic imaging
Humans
Male
Pilot Projects
Retrospective Studies
Cerebellar Nuclei drug effects
Cerebellar Nuclei metabolism
Fluorodeoxyglucose F18 metabolism
Gadolinium pharmacology
Globus Pallidus drug effects
Globus Pallidus metabolism
Positron Emission Tomography Computed Tomography
Subjects
Details
- Language :
- English
- ISSN :
- 1535-5675
- Volume :
- 45
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Journal of nuclear medicine technology
- Publication Type :
- Academic Journal
- Accession number :
- 27834725
- Full Text :
- https://doi.org/10.2967/jnmt.116.180844